Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 45 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
"PHARMACIE PENNINCK" from Mons, company number BE0786972183, closed financial year 2025 with a result of € 67,640 after tax. For that financial year "PHARMACIE PENNINCK" recorded a gross margin of € 178,479 and equity of € 73,000. Compared with financial year 2024, the result moved from € 59,366 to € 67,640. Profitable, and profit is growing. The buffer shrank hard: equity is 59 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.
€ 73,000
▼ 59% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 67,640
▲ 14% vs 2024
Profit after tax over the fiscal year.
€ 93,894
▲ 18% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 173,518 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
0.1
Average over the fiscal year, from the social balance sheet.
€ 5,872
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 29,766
▼ 34% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 464,961
▼ 9% vs 2024
€ 49,876 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 38,837
▼ 53% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,565
▼ 3% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 63,026 | € 119,783 | € 164,187 | € 178,479 | ▲ 9% |
| Profit after taxes | € 20,084 | € 31,360 | € 59,366 | € 67,640 | ▲ 14% |
| Equity | € 26,785 | € 120,345 | € 178,878 | € 73,000 | ▼ 59% |
| Total debts | € 695,205 | € 800,891 | € 729,492 | € 770,339 | ▲ 6% |
| Cash | € 120,322 | € 116,971 | € 79,752 | € 93,894 | ▲ 18% |
| Land & buildings | € 180,508 | € 351,761 | € 339,424 | € 322,936 | ▼ 5% |
| Retained profit | € 16,784 | € 47,345 | € 105,878 | € 0 | ▼ 100% |
| Dividend | € 3,300 | € 800 | € 833 | € 173,518 | ▲ € 172,685 |
| Bank debt | € 392,480 | € 557,731 | € 513,289 | € 464,961 | ▼ 9% |
| Balance sheet total | € 721,990 | € 921,235 | € 908,369 | € 843,339 | ▼ 7% |
| Employees (FTE) | - | - | 0 | 0.1 |
By gross margin, "PHARMACIE PENNINCK" ranks 4th of 5 companies with main activity “Detailhandel in farmaceutische producten” in Mons that publish figures (fiscal year 2025).
Key figures of "PHARMACIE PENNINCK", fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about "PHARMACIE PENNINCK" the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to "PHARMACIE PENNINCK"?
What happened at "PHARMACIE PENNINCK" in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 67,640 (▲ 14% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Mons. KBO
- LAURENCE PENNINCK became a director. NBB
In short
From € 20,084 profit in 2022 to € 67,640 profit in 2025.
Paid € 45,854 in corporate taxes since 2022.
Best year ever: 2025, with € 67,640 profit.
Paid out € 178,451 in dividends to the owners in total.
Management
Behind "PHARMACIE PENNINCK" is LAURENCE PENNINCK.
Directors
According to the 2025 annual accounts
LAURENCE PENNINCK
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Av. Champ de Bataille (Jem. II) 483
7012 Mons
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Mons
Same main activity (Detailhandel in farmaceutische producten), 5 active companies in Mons, largest first.
€ 795,765 gross margin · 2025
€ 447,699 gross margin · 2025
€ 271,075 gross margin · 2025
€ 119,483 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- PENNINCK Laurence(oprichter) 100%
Details
- Company number
- 0786.972.183
- VAT number
- BE 0786.972.183
- Registered office
- Av. Champ de Bataille (Jem. II) 483, 7012 Mons
- Names & denominations
- "PHARMACIE PENNINCK"
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 June 2022
- Peppol
- Active · Active since 15 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten